Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Bradley Martin

Concepts (373)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Analgesics, Opioid
43
2024
587
8.470
 Why?
Chronic Pain
17
2024
178
5.740
 Why?
Opioid-Related Disorders
17
2024
399
3.980
 Why?
Drug Overdose
11
2024
163
3.790
 Why?
Medicaid
23
2021
263
2.660
 Why?
Drug Prescriptions
15
2024
104
2.550
 Why?
Alcoholism
4
2022
237
2.340
 Why?
Tramadol
3
2024
30
2.330
 Why?
Antipsychotic Agents
10
2018
235
1.900
 Why?
Retrospective Studies
45
2025
6610
1.770
 Why?
Adult
59
2025
14095
1.690
 Why?
Anticoagulants
7
2025
276
1.680
 Why?
Middle Aged
59
2025
13028
1.650
 Why?
United States
53
2024
5168
1.640
 Why?
Humans
112
2025
52114
1.560
 Why?
Pain
11
2022
353
1.450
 Why?
Osteoarthritis, Knee
3
2017
97
1.440
 Why?
Health Care Costs
10
2022
174
1.320
 Why?
Female
74
2025
28055
1.310
 Why?
Young Adult
29
2025
4307
1.310
 Why?
Adolescent
38
2024
6681
1.290
 Why?
Aged
44
2025
10142
1.280
 Why?
Male
70
2025
26652
1.270
 Why?
Atrial Fibrillation
4
2016
200
1.210
 Why?
Viscosupplements
3
2017
14
1.200
 Why?
Asthma
4
2017
314
1.190
 Why?
Hyaluronic Acid
3
2017
38
1.180
 Why?
Mental Disorders
7
2025
426
1.150
 Why?
Medication Adherence
6
2016
132
1.130
 Why?
Emergency Service, Hospital
6
2016
515
1.100
 Why?
Schizophrenia
5
2009
253
1.070
 Why?
Cross-Over Studies
2
2025
238
1.050
 Why?
Cohort Studies
17
2024
1541
1.030
 Why?
Arthroplasty, Replacement, Knee
4
2017
289
1.020
 Why?
Analgesics, Non-Narcotic
3
2012
117
1.000
 Why?
Substance-Related Disorders
5
2021
609
0.990
 Why?
Acetaminophen
4
2015
277
0.990
 Why?
Venous Thromboembolism
2
2025
75
0.960
 Why?
Warfarin
4
2016
82
0.960
 Why?
Patient Compliance
6
2009
229
0.950
 Why?
Veterans
10
2024
579
0.920
 Why?
Psychotropic Drugs
1
2025
76
0.880
 Why?
Psychotherapy
1
2025
112
0.850
 Why?
Suicide
1
2025
85
0.830
 Why?
Prescription Drugs
6
2014
40
0.820
 Why?
Cost-Benefit Analysis
5
2020
267
0.810
 Why?
Insurance, Health
7
2020
133
0.780
 Why?
Risk Factors
15
2025
3922
0.770
 Why?
Attention Deficit Disorder with Hyperactivity
1
2023
179
0.740
 Why?
Neck Pain
2
2021
10
0.730
 Why?
Back Pain
2
2021
39
0.720
 Why?
Arkansas
14
2024
2016
0.720
 Why?
Central Nervous System Stimulants
1
2023
199
0.720
 Why?
Drug Utilization
11
2017
77
0.710
 Why?
Arthralgia
1
2021
44
0.690
 Why?
Hospitalization
6
2016
739
0.690
 Why?
Professional-Patient Relations
1
2021
46
0.690
 Why?
Insurance, Pharmaceutical Services
2
2019
25
0.680
 Why?
Stroke
3
2016
514
0.680
 Why?
Decision Support Techniques
3
2016
70
0.680
 Why?
Logistic Models
8
2016
925
0.650
 Why?
Narcotic Antagonists
2
2024
138
0.650
 Why?
Naloxone
1
2020
78
0.620
 Why?
Breast Neoplasms
4
2023
1199
0.620
 Why?
Hydrocodone
3
2024
20
0.610
 Why?
Oxycodone
3
2024
26
0.600
 Why?
Legislation, Drug
1
2019
18
0.590
 Why?
Contraception
1
2019
30
0.590
 Why?
Proton Pump Inhibitors
2
2016
86
0.580
 Why?
Adrenal Cortex Hormones
2
2017
114
0.560
 Why?
Follow-Up Studies
8
2024
2282
0.550
 Why?
Buprenorphine
3
2024
150
0.540
 Why?
Guidelines as Topic
1
2018
111
0.540
 Why?
Mammography
1
2018
97
0.540
 Why?
Practice Guidelines as Topic
3
2017
494
0.530
 Why?
Histamine H2 Antagonists
1
2016
26
0.520
 Why?
Peptic Ulcer
1
2016
14
0.520
 Why?
Purinergic P2Y Receptor Antagonists
3
2022
35
0.490
 Why?
Education, Pharmacy, Graduate
1
2016
19
0.490
 Why?
Pyridones
1
2016
36
0.490
 Why?
Risk
4
2020
312
0.480
 Why?
Inappropriate Prescribing
1
2016
23
0.480
 Why?
Safety-Based Drug Withdrawals
1
2015
7
0.470
 Why?
Dextropropoxyphene
1
2015
6
0.470
 Why?
Insurance Claim Review
5
2010
39
0.470
 Why?
Health Expenditures
3
2011
74
0.470
 Why?
Tobacco Use Cessation
1
2015
10
0.470
 Why?
For-Profit Insurance Plans
1
2015
2
0.470
 Why?
Databases, Factual
11
2022
714
0.470
 Why?
Brain Ischemia
2
2016
161
0.460
 Why?
Pyrazoles
1
2016
113
0.460
 Why?
Mass Screening
1
2018
356
0.450
 Why?
Quinolines
1
2015
43
0.450
 Why?
Time Factors
9
2018
2970
0.450
 Why?
Acetates
1
2015
51
0.450
 Why?
Stress, Psychological
1
2016
273
0.440
 Why?
Opiate Substitution Treatment
3
2024
102
0.440
 Why?
Diabetic Neuropathies
1
2015
56
0.440
 Why?
Anticonvulsants
2
2006
133
0.440
 Why?
Insurance Claim Reporting
2
2011
11
0.440
 Why?
Low Back Pain
2
2025
31
0.430
 Why?
Critical Illness
1
2016
310
0.430
 Why?
Curriculum
2
2018
392
0.430
 Why?
Controlled Substances
2
2024
7
0.420
 Why?
Palliative Care
1
2016
195
0.420
 Why?
Pain Management
1
2015
175
0.420
 Why?
Aged, 80 and over
13
2023
3382
0.410
 Why?
Tobacco Products
1
2015
127
0.410
 Why?
Neoplasms
1
2023
1288
0.400
 Why?
Injections, Intra-Articular
3
2017
38
0.400
 Why?
Computers, Handheld
1
2013
23
0.400
 Why?
Prescription Drug Misuse
3
2024
33
0.400
 Why?
Evidence-Based Medicine
3
2014
270
0.390
 Why?
Neuralgia
2
2023
42
0.380
 Why?
United States Department of Veterans Affairs
5
2024
292
0.380
 Why?
Age Factors
6
2018
1125
0.380
 Why?
Quality-Adjusted Life Years
3
2020
67
0.380
 Why?
Benzodiazepines
3
2024
71
0.370
 Why?
Cross-Sectional Studies
6
2022
1665
0.370
 Why?
Health Knowledge, Attitudes, Practice
1
2015
503
0.350
 Why?
Case-Control Studies
7
2023
1193
0.350
 Why?
Community Pharmacy Services
3
2020
66
0.340
 Why?
Medicare
6
2023
273
0.330
 Why?
Health Personnel
1
2013
251
0.320
 Why?
Kidney Failure, Chronic
2
2022
212
0.310
 Why?
Employment
2
2015
93
0.310
 Why?
Age Distribution
5
2018
174
0.310
 Why?
Antidepressive Agents
2
2009
176
0.300
 Why?
Motor Vehicles
1
2009
14
0.300
 Why?
Propensity Score
3
2022
157
0.300
 Why?
Automobile Driving
1
2009
27
0.300
 Why?
Medication Errors
1
2009
24
0.300
 Why?
Pharmacists
3
2019
141
0.290
 Why?
Prevalence
5
2018
1013
0.290
 Why?
Hemorrhage
3
2023
222
0.290
 Why?
Cost of Illness
3
2013
120
0.280
 Why?
Physicians, Primary Care
2
2018
46
0.280
 Why?
Pain Measurement
6
2021
256
0.280
 Why?
Health Resources
2
2012
72
0.280
 Why?
College Admission Test
2
2018
13
0.270
 Why?
Antimanic Agents
1
2007
14
0.270
 Why?
School Admission Criteria
2
2018
35
0.260
 Why?
Schools, Pharmacy
2
2018
55
0.260
 Why?
Child
10
2019
7147
0.260
 Why?
Markov Chains
2
2020
29
0.260
 Why?
Pharmaceutical Services
2
2018
50
0.260
 Why?
Georgia
6
2006
42
0.260
 Why?
Constipation
1
2006
37
0.250
 Why?
Postoperative Complications
2
2025
1071
0.250
 Why?
Hypoglycemic Agents
1
2008
217
0.250
 Why?
Orthopedic Procedures
2
2017
71
0.250
 Why?
Overweight
1
2009
230
0.250
 Why?
Multivariate Analysis
4
2017
600
0.250
 Why?
Least-Squares Analysis
4
2011
44
0.250
 Why?
United States Food and Drug Administration
4
2011
90
0.240
 Why?
Knee Joint
2
2017
165
0.240
 Why?
Platelet Aggregation Inhibitors
2
2021
211
0.240
 Why?
Students, Pharmacy
2
2018
123
0.240
 Why?
Odds Ratio
4
2020
564
0.230
 Why?
Risperidone
2
2010
25
0.230
 Why?
Colectomy
1
2025
35
0.230
 Why?
North Carolina
5
2011
55
0.220
 Why?
Polypharmacy
1
2004
15
0.220
 Why?
Drug Costs
2
2020
39
0.220
 Why?
General Practitioners
1
2023
4
0.210
 Why?
Severity of Illness Index
3
2017
1035
0.210
 Why?
Patient Selection
1
2025
265
0.210
 Why?
Haloperidol
1
2003
46
0.200
 Why?
Renal Dialysis
2
2022
190
0.200
 Why?
Motivation
1
2025
281
0.200
 Why?
Direct Service Costs
1
2003
4
0.200
 Why?
Irritable Bowel Syndrome
1
2003
17
0.200
 Why?
Aftercare
1
2023
70
0.200
 Why?
Dose-Response Relationship, Drug
5
2014
1368
0.200
 Why?
Premedication
1
2002
17
0.190
 Why?
Diabetes Mellitus, Type 2
1
2008
562
0.190
 Why?
Health Services Needs and Demand
1
2004
159
0.190
 Why?
Common Cold
1
2002
5
0.190
 Why?
Bronchitis
1
2002
10
0.190
 Why?
Thromboembolism
1
2002
49
0.180
 Why?
Advisory Committees
3
2018
72
0.180
 Why?
Proportional Hazards Models
4
2017
439
0.180
 Why?
Accidents
1
2021
20
0.180
 Why?
Respiratory Insufficiency
1
2023
115
0.180
 Why?
Carcinoma, Non-Small-Cell Lung
1
2023
166
0.180
 Why?
Depressive Disorder, Major
2
2020
148
0.180
 Why?
Colorectal Neoplasms
1
2025
292
0.180
 Why?
Forecasting
3
2009
152
0.180
 Why?
Ambulatory Care Facilities
1
2002
124
0.170
 Why?
Mental Health Services
1
2004
210
0.170
 Why?
Delivery of Health Care
2
2021
318
0.170
 Why?
Respiratory Tract Infections
1
2002
81
0.170
 Why?
Patient Discharge
1
2023
322
0.170
 Why?
Interprofessional Relations
2
2018
90
0.170
 Why?
Afghan Campaign 2001-
2
2018
40
0.170
 Why?
Regression Analysis
5
2013
399
0.170
 Why?
Administration, Oral
2
2016
453
0.170
 Why?
Obesity
1
2009
1183
0.160
 Why?
Decision Making
5
2018
277
0.160
 Why?
Administration, Intranasal
1
2020
30
0.160
 Why?
Brain Neoplasms
1
2023
287
0.160
 Why?
Cardiovascular Diseases
2
2018
493
0.160
 Why?
Economics, Pharmaceutical
2
2009
6
0.160
 Why?
Selection Bias
2
2009
15
0.160
 Why?
Social Media
1
2022
116
0.160
 Why?
Comparative Effectiveness Research
2
2009
47
0.160
 Why?
Preventive Health Services
1
2020
52
0.160
 Why?
Child, Preschool
5
2011
4001
0.150
 Why?
Drug Administration Schedule
3
2011
374
0.150
 Why?
Coronary Restenosis
1
2019
39
0.150
 Why?
Sepsis
1
2021
229
0.150
 Why?
Guideline Adherence
3
2025
141
0.150
 Why?
Insurance Coverage
1
2020
114
0.150
 Why?
Health Care Surveys
2
2011
176
0.140
 Why?
Public Health Surveillance
1
2018
18
0.140
 Why?
Thiazoles
2
2016
52
0.140
 Why?
Sleep Deprivation
1
2018
18
0.140
 Why?
Papillomavirus Vaccines
1
2019
69
0.140
 Why?
Pharmacies
1
2019
60
0.140
 Why?
Physicians
1
2021
235
0.140
 Why?
Chronic Disease
5
2011
585
0.140
 Why?
Metabolic Diseases
1
2018
47
0.140
 Why?
Veterans Health
2
2014
64
0.130
 Why?
Lung Neoplasms
1
2023
624
0.130
 Why?
Molecular Weight
1
2017
77
0.130
 Why?
Acute Pain
1
2017
11
0.130
 Why?
Coronary Vessels
1
2019
172
0.130
 Why?
Papillomavirus Infections
1
2019
171
0.130
 Why?
Fractional Flow Reserve, Myocardial
1
2019
127
0.130
 Why?
Coronary Angiography
1
2019
384
0.130
 Why?
Educational Measurement
1
2018
194
0.130
 Why?
Treatment Outcome
7
2010
5456
0.130
 Why?
Eosinophils
1
2017
40
0.130
 Why?
Monte Carlo Method
1
2016
88
0.130
 Why?
Early Detection of Cancer
1
2018
183
0.120
 Why?
Chilaiditi Syndrome
1
2015
1
0.120
 Why?
Education, Pharmacy
1
2018
150
0.120
 Why?
Anti-Bacterial Agents
1
2002
796
0.120
 Why?
Incidental Findings
1
2015
41
0.120
 Why?
Geriatrics
1
2016
41
0.120
 Why?
India
1
2015
58
0.120
 Why?
Health Services Accessibility
1
2020
438
0.120
 Why?
Sex Distribution
1
2015
138
0.120
 Why?
Health Policy
3
2011
160
0.110
 Why?
Models, Theoretical
1
2016
182
0.110
 Why?
Sulfides
1
2015
29
0.110
 Why?
Cyclopropanes
1
2015
27
0.110
 Why?
Thrombosis
1
2018
252
0.110
 Why?
Pyridines
1
2016
134
0.110
 Why?
Income
1
2015
103
0.110
 Why?
Coronary Artery Disease
1
2019
317
0.110
 Why?
Anti-Asthmatic Agents
1
2015
33
0.110
 Why?
Renal Insufficiency, Chronic
1
2018
201
0.110
 Why?
Sarcopenia
1
2015
98
0.110
 Why?
Societies, Medical
1
2016
200
0.110
 Why?
Self Report
1
2016
218
0.110
 Why?
Long-Term Care
3
2012
51
0.110
 Why?
Educational Status
1
2015
227
0.110
 Why?
Disease Progression
1
2017
866
0.100
 Why?
Enoxaparin
2
2025
31
0.100
 Why?
California
2
2004
87
0.100
 Why?
Comorbidity
5
2017
628
0.100
 Why?
Health Literacy
1
2015
131
0.100
 Why?
Health Behavior
1
2015
256
0.100
 Why?
Monitoring, Physiologic
1
2013
122
0.100
 Why?
Prescriptions
2
2011
11
0.100
 Why?
Sensitivity and Specificity
1
2015
871
0.100
 Why?
Risk Assessment
2
2015
1339
0.100
 Why?
Infant
3
2011
3660
0.090
 Why?
Drug Therapy, Combination
2
2004
399
0.090
 Why?
Managed Care Programs
1
2012
36
0.090
 Why?
Ticlopidine
1
2012
72
0.090
 Why?
Predictive Value of Tests
2
2019
939
0.090
 Why?
Randomized Controlled Trials as Topic
2
2025
608
0.090
 Why?
Deductibles and Coinsurance
1
2011
2
0.090
 Why?
Hypertension, Pulmonary
1
2012
110
0.080
 Why?
Body Mass Index
2
2013
699
0.080
 Why?
Calibration
1
2009
56
0.080
 Why?
International Classification of Diseases
1
2009
67
0.080
 Why?
Clozapine
2
2010
25
0.080
 Why?
Analysis of Variance
1
2010
554
0.080
 Why?
Reference Values
1
2009
313
0.070
 Why?
Treatment Refusal
1
2009
35
0.070
 Why?
Carbamazepine
1
2007
13
0.070
 Why?
Lithium Compounds
1
2007
12
0.070
 Why?
Mental Health
1
2010
237
0.070
 Why?
Alendronate
1
2007
24
0.070
 Why?
Fractures, Spontaneous
1
2007
14
0.070
 Why?
Valproic Acid
1
2007
35
0.070
 Why?
Internationality
3
2014
46
0.070
 Why?
Chemotherapy, Adjuvant
1
2007
121
0.060
 Why?
Osteoporosis, Postmenopausal
1
2007
29
0.060
 Why?
Affect
1
2007
105
0.060
 Why?
Drug Labeling
1
2006
11
0.060
 Why?
Bone Density Conservation Agents
1
2007
75
0.060
 Why?
Data Collection
2
2009
286
0.060
 Why?
Adrenergic beta-Agonists
1
2005
42
0.060
 Why?
Self Disclosure
1
2005
12
0.060
 Why?
Australia
1
2025
90
0.060
 Why?
Multicenter Studies as Topic
1
2025
112
0.060
 Why?
Drug Interactions
2
2018
201
0.060
 Why?
Depression
1
2009
603
0.060
 Why?
Factor Analysis, Statistical
1
2004
86
0.050
 Why?
Eligibility Determination
1
2004
21
0.050
 Why?
Urban Population
1
2005
161
0.050
 Why?
Health Surveys
2
2018
238
0.050
 Why?
Prescription Fees
1
2004
14
0.050
 Why?
Length of Stay
1
2007
666
0.050
 Why?
Algorithms
1
2007
663
0.050
 Why?
Laparoscopy
1
2025
180
0.050
 Why?
Data Interpretation, Statistical
3
2009
168
0.050
 Why?
MEDLINE
1
2002
8
0.050
 Why?
Prospective Studies
1
2008
2424
0.050
 Why?
SEER Program
1
2023
102
0.050
 Why?
Cognition Disorders
1
2003
195
0.050
 Why?
Antidepressive Agents, Second-Generation
1
2002
27
0.050
 Why?
Quality of Life
2
2023
878
0.050
 Why?
Neuropsychological Tests
1
2003
333
0.050
 Why?
Analgesics
1
2023
103
0.050
 Why?
Pharmacy
2
2018
54
0.040
 Why?
Gastrointestinal Hemorrhage
1
2022
91
0.040
 Why?
Longitudinal Studies
2
2014
742
0.040
 Why?
Patient Protection and Affordable Care Act
1
2020
52
0.040
 Why?
Needs Assessment
1
2020
139
0.040
 Why?
Ohio
1
2019
45
0.040
 Why?
Myocardial Revascularization
1
2019
29
0.040
 Why?
Quality of Health Care
1
2020
187
0.040
 Why?
Incidence
2
2014
1070
0.030
 Why?
Pharmacoepidemiology
1
2017
8
0.030
 Why?
Universities
1
2018
172
0.030
 Why?
Research Design
2
2014
367
0.030
 Why?
Vaccination
1
2019
296
0.030
 Why?
Pilot Projects
1
2019
712
0.030
 Why?
Communication
1
2018
254
0.030
 Why?
Qualitative Research
1
2018
358
0.030
 Why?
Electronic Health Records
1
2018
267
0.030
 Why?
Attitude of Health Personnel
1
2018
358
0.030
 Why?
Ischemic Attack, Transient
1
2013
59
0.020
 Why?
Survival Analysis
1
2014
667
0.020
 Why?
Lipids
1
2013
159
0.020
 Why?
Linear Models
1
2013
290
0.020
 Why?
Diagnosis, Dual (Psychiatry)
1
2012
40
0.020
 Why?
Stress Disorders, Post-Traumatic
1
2017
394
0.020
 Why?
Diagnostic Tests, Routine
1
2012
31
0.020
 Why?
Cost Control
1
2011
13
0.020
 Why?
Blood Pressure
1
2013
535
0.020
 Why?
Acute Coronary Syndrome
1
2012
106
0.020
 Why?
Blood Glucose
1
2013
475
0.020
 Why?
Reproducibility of Results
2
2005
1214
0.020
 Why?
Adolescent Behavior
1
2011
105
0.020
 Why?
Dibenzothiazepines
1
2010
10
0.020
 Why?
Hypnotics and Sedatives
1
2010
70
0.020
 Why?
Off-Label Use
1
2010
24
0.020
 Why?
Observation
1
2009
8
0.020
 Why?
Epidemiologic Methods
1
2009
46
0.020
 Why?
Diabetes Mellitus
1
2013
316
0.020
 Why?
Causality
1
2009
53
0.020
 Why?
Mood Disorders
1
2009
59
0.020
 Why?
Quinolones
1
2010
50
0.020
 Why?
Anxiety Disorders
1
2009
130
0.020
 Why?
Piperazines
1
2010
125
0.020
 Why?
ROC Curve
1
2009
250
0.020
 Why?
Headache
1
2008
75
0.020
 Why?
Sex Factors
1
2009
731
0.020
 Why?
Confidence Intervals
1
2007
159
0.020
 Why?
Probability
1
2007
171
0.020
 Why?
Drug Utilization Review
1
2005
22
0.010
 Why?
Drug Monitoring
1
2005
82
0.010
 Why?
Bone Density
1
2007
394
0.010
 Why?
Registries
1
2007
629
0.010
 Why?
Health Maintenance Organizations
1
2002
16
0.010
 Why?
Antidepressive Agents, Tricyclic
1
2002
28
0.010
 Why?
Costs and Cost Analysis
1
2002
95
0.010
 Why?
Martin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (373) concept(s)
_
Co-Authors Expand Description
See all (53) people
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department